HomeCRVS • NASDAQ
add
Corvus Pharmaceuticals Inc
Previous close
$8.67
Day range
$8.31 - $8.74
Year range
$2.54 - $9.60
Market cap
634.05M USD
Avg Volume
1.09M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.57M | 45.72% |
Net income | -10.16M | 74.74% |
Net profit margin | — | — |
Earnings per share | -0.12 | 80.00% |
EBITDA | -10.54M | -45.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 65.69M | 57.71% |
Total assets | 80.47M | 36.83% |
Total liabilities | 8.71M | -81.24% |
Total equity | 71.77M | — |
Shares outstanding | 74.68M | — |
Price to book | 9.03 | — |
Return on assets | -31.11% | — |
Return on capital | -34.30% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -10.16M | 74.74% |
Cash from operations | -9.57M | -51.34% |
Cash from investing | -2.62M | 32.70% |
Cash from financing | 360.00K | 620.00% |
Net change in cash | -11.82M | -16.37% |
Free cash flow | -5.67M | -119.29% |
About
Founded
2014
Headquarters
Website
Employees
31
